inno.N
Manufacturing · South Korea · 11-50 Employees
View Company Info for Free
Overview
Headquarters
811 Deokpyeong-ro Deokpyeong-ri Majang-m...Phone Number
+82 316291620Website
www.inno-n.comRevenue
$10.4 MillionIndustry
About inno.N
inno.N Org Chart
Is inno.N your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
inno.N, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if inno.N is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at inno.N
Product Launch: Get notified when inno.N launches new products
Funding: Get notified immidiatlly once inno.N has new funding data
Earning: See what the market has to say on inno.N recently announced quarterly report
Click to see if inno.N had a recent Job posting/layoffs
Check if inno.N has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
inno.N is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
inno.N is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about inno.N.
inno.N Tech Stack
A closer look at the technologies used by inno.N
inno.N News & Media
Sciwind Biosciences and HK inno.N Corporation Announce Licensing and Partnership Agreement for Ecnoglutide Injection (XW003) in South Korea
HANGZHOU, China and SEOUL, South Korea, May 7, 2024 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical stage biopharmaceutical company focused on developing treatments for metabolic disease, and HK inno.N Corporation, a South Korean commercial stage pharmaceutical company (KOSDAQ:...Sebela Pharmaceuticals® Acquires Exclusive Licensing Rights to Develop and Commercialize Tegoprazan in the U.S. and Canada
Sebela Pharmaceuticals® has entered an exclusive partnership with HK inno.N Corporation to license tegoprazan in the United States and Canada. Under the agreement, Braintree Laboratories, a leader in gastroenterology and an affiliate of Sebela Pharmaceuticals, will be responsible for clinical development, registration, marketing, and sales in the United States and Canada. Tegoprazan, a novel potassium-competitive acid-blocker (P-CAB), is currently approved and marketed in several territories, inSebela Pharmaceuticals® Acquires Exclusive Licensing Rights to Develop and Commercialize Tegoprazan in the U.S. and Canada
Phase 3 Trials Initiated with Tegoprazan for the Treatment of Erosive Esophagitis and Non-erosive Reflux Disease BRAINTREE, Mass., Oct. 19, 2022 /PRNewswire/ -- Sebela Pharmaceuticals® has entered an exclusive partnership with HK inno.N Corporation to license tegoprazan in the United...GICELL Announces Research Collaboration with HK inno.N for next-generation CAR-NK therapy
SEOUL, South Korea--(BUSINESS WIRE)-- #CAR_NK--GICELL and HK inno.N announced R&D collaboration for allogeneic CAR-NK candidates.
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding inno.N
HK이노엔 is a leading global biohealth company specializing in innovative pharmaceuticals, health, beauty, and beverage products. The company offers a range of prescription medications, health supplements, and beauty products, including its well-known brands like 케이캡 and 비원츠. With a strong focus on research and development, HK이노엔 aims to create health... Read More